Document is current
Any future updates will be listed below
-
Authors
Li, Chunwang
Zhuo, Lingyun
Kang, Yaqing
Liu, Penghui
Huang, Weilin
Li, Qixuan
Ma, Ke
Huang, Shuna
Lin, Xinru
Zhuang, Weiheng
Wang, Haojie
Chen, Darong
Wang, Huimin
He, Qiu
Gao, Zhuyu https://orcid.org/0009-0000-9511-6126
Niu, Xuegang
Jing, Yajun https://orcid.org/0000-0002-1291-4104
Yan, Lingjun
Gao, Bin
Wang, Dengliang
Lin, Shaowei
Wu, Siying
Lin, Yuanxiang
Kang, Dezhi https://orcid.org/0000-0002-0906-9456
Lin, Fuxin https://orcid.org/0000-0001-5803-2644
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03467295 at ClinicalTrials.govDocuments that mention this clinical trial
Plasma biomarkers in patients with familial cavernous malformation and their first-degree relatives: a cross-sectional study
https://doi.org/10.1038/s41598-025-91141-6
Treatments and outcomes of untreated cerebral cavernous malformations in China: study protocol of a nationwide multicentre prospective cohort study (Pre-results)
https://doi.org/10.1136/bmjopen-2020-037957
Prevalence, genetic and clinical characteristics in first-degree relatives of patients with familial cerebral cavernous malformations in China
https://doi.org/10.1136/svn-2023-003004
-
Funding
Funding for this research was provided by:
Fujian Province High level Neuromedical Center Construction Fund (HLNCC-FJFY-003)
National Natural Science Foundation of China (8227051360)
Technology Platform Construction Project of Fujian Province (2020Y2003, 2021Y2001)
- License Information
